180 related articles for article (PubMed ID: 38723900)
21. Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.
Luna E; Luk KC
FEBS Lett; 2015 Dec; 589(24 Pt A):3749-59. PubMed ID: 26505673
[TBL] [Abstract][Full Text] [Related]
22. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639
[TBL] [Abstract][Full Text] [Related]
23. Loss of functional alpha-synuclein: a toxic event in Parkinson's disease?
Kanaan NM; Manfredsson FP
J Parkinsons Dis; 2012; 2(4):249-67. PubMed ID: 23938255
[TBL] [Abstract][Full Text] [Related]
24. Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy.
Tanik SA; Schultheiss CE; Volpicelli-Daley LA; Brunden KR; Lee VM
J Biol Chem; 2013 May; 288(21):15194-210. PubMed ID: 23532841
[TBL] [Abstract][Full Text] [Related]
25. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.
Mahul-Mellier AL; Burtscher J; Maharjan N; Weerens L; Croisier M; Kuttler F; Leleu M; Knott GW; Lashuel HA
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4971-4982. PubMed ID: 32075919
[TBL] [Abstract][Full Text] [Related]
26. Decreased AQP4 Expression Aggravates ɑ-Synuclein Pathology in Parkinson's Disease Mice, Possibly via Impaired Glymphatic Clearance.
Cui H; Wang W; Zheng X; Xia D; Liu H; Qin C; Tian H; Teng J
J Mol Neurosci; 2021 Dec; 71(12):2500-2513. PubMed ID: 33772424
[TBL] [Abstract][Full Text] [Related]
27. Distinct Effects of Familial Parkinson's Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation.
Xu B; Fan F; Liu Y; Liu Y; Zhou L; Yu H
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238596
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapeutic interventions in Parkinson's disease: Focus on α-Synuclein.
Ganguly U; Singh S; Chakrabarti S; Saini AK; Saini RV
Adv Protein Chem Struct Biol; 2022; 129():381-433. PubMed ID: 35305723
[TBL] [Abstract][Full Text] [Related]
29. Molecular events underlying the cell-to-cell transmission of α-synuclein.
Choi YR; Park SJ; Park SM
FEBS J; 2021 Dec; 288(23):6593-6602. PubMed ID: 33332736
[TBL] [Abstract][Full Text] [Related]
30. Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology.
Hayakawa H; Nakatani R; Ikenaka K; Aguirre C; Choong CJ; Tsuda H; Nagano S; Koike M; Ikeuchi T; Hasegawa M; Papa SM; Nagai Y; Mochizuki H; Baba K
Mov Disord; 2020 Feb; 35(2):256-267. PubMed ID: 31643109
[TBL] [Abstract][Full Text] [Related]
31. The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses.
Jan A; Gonçalves NP; Vaegter CB; Jensen PH; Ferreira N
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361100
[TBL] [Abstract][Full Text] [Related]
32. Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson's disease.
Park SJ; Jin U; Park SM
PLoS Pathog; 2021 Oct; 17(10):e1010018. PubMed ID: 34695168
[TBL] [Abstract][Full Text] [Related]
33. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.
Volpicelli-Daley LA; Luk KC; Patel TP; Tanik SA; Riddle DM; Stieber A; Meaney DF; Trojanowski JQ; Lee VM
Neuron; 2011 Oct; 72(1):57-71. PubMed ID: 21982369
[TBL] [Abstract][Full Text] [Related]
34. Models of α-synuclein aggregation in Parkinson's disease.
Giráldez-Pérez R; Antolín-Vallespín M; Muñoz M; Sánchez-Capelo A
Acta Neuropathol Commun; 2014 Dec; 2():176. PubMed ID: 25497491
[TBL] [Abstract][Full Text] [Related]
35. Progression of phosphorylated α-synuclein in Macaca fuscata.
Kawakami I; Motoda A; Hashimoto M; Shimozawa A; Masuda-Suzukake M; Ohtani R; Takase M; Kumashiro M; Samejima K; Hasegawa M
Brain Pathol; 2021 Sep; 31(5):e12952. PubMed ID: 33754430
[TBL] [Abstract][Full Text] [Related]
36. [Alpha-synuclein interacted proteins: the relevance with the pathogenesis of Parkinson's disease].
Xu F; Luo JH; Jin JH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 37(5):524-30. PubMed ID: 18925724
[TBL] [Abstract][Full Text] [Related]
37. Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.
Peng C; Gathagan RJ; Covell DJ; Medellin C; Stieber A; Robinson JL; Zhang B; Pitkin RM; Olufemi MF; Luk KC; Trojanowski JQ; Lee VM
Nature; 2018 May; 557(7706):558-563. PubMed ID: 29743672
[TBL] [Abstract][Full Text] [Related]
38. Modeling Lewy pathology propagation in Parkinson's disease.
Luk KC; Lee VM
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1(0 1):S85-7. PubMed ID: 24262196
[TBL] [Abstract][Full Text] [Related]
39. [The role of alpha-synuclein in Parkinson's disease].
Miklya I; Pencz N; Hafenscher F; Göltl P
Neuropsychopharmacol Hung; 2014 Jun; 16(2):77-84. PubMed ID: 24978050
[TBL] [Abstract][Full Text] [Related]
40. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
Wu J; Lou H; Alerte TN; Stachowski EK; Chen J; Singleton AB; Hamilton RL; Perez RG
Neuroscience; 2012 Apr; 207():288-97. PubMed ID: 22326202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
